Links and Resources
On This Page
TATFAR Reports and Publications
Progress Reports
- 2021 TATFAR Progress Report pdf icon[PDF – 47 Pages]
- 2014 TATFAR Progress Report pdf icon[PDF – 86 Pages]
- 2011 Report pdf icon[PDF – 47 Pages]
Publications
- 2019 Targets for the reduction of Antibiotic Use in humansexternal icon
- 2017 Pull Incentives for Antibacterial Drug Developmentexternal icon
- 2016 Economic Incentives for Antimicrobial Therapy Development pdf icon[PDF – 28 Pages]external icon
- 2015 Report on the modified Delphi process for common structure and process indicators for hospital antimicrobial stewardship programs pdf icon[PDF – 67 Pages]
- Using Available Data Sources at the Country Level to Track Antibiotic Use pdf icon[PDF – 10 Pages]
Video Clips
Historical Documents
Key Publications
Antibiotic Resistance Action Plans
- Canada: Tackling Antimicrobial Resistance and Antimicrobial Use: A Pan-Canadian Framework for Action external icon
- European Union: A European One Health Action Plan against Antimicrobial Resistance (AMR) pdf icon[PDF – 24 Pages]external icon
- Norway: Norwegian National Strategy Against Antibiotic Resistance 2015-2020external icon
- United States: United States National Action Plan for Combating Antibiotic-Resistant Bacteria
Center for Disease Control and Prevention
- Antibiotic Resistance Threats in the United States, 2019 (2019 AR Threats Report)
- Initiatives for Addressing Antimicrobial Resistance in the Environment are two corresponding reports published in 2018 providing an overview of the current evidence base and ongoing knowledge gaps around antibiotic resistant in the environment (e.g., water, soil) and the potential effect on human health.
- Antibiotic Use in the United States, 2017: Progress and Opportunities
European Centre for Disease Prevention and Control
- Will COVID-19 have an impact on AMR?external icon
- Cross-border spread of blaNDM-1– and blaOXA-48-positive Klebsiella pneumoniae: A European collaborative analysis of whole genome sequencing and epidemiological data, 2014 to 2019external icon
- ECDC/EFSA/EMA second joint report on the integrated analysis of the consumption of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from humans and food-producing animals, 2017 pdf icon[PDF – 135 Pages]external icon
- ECDC/EFSA/EMA first joint report on the integrated analysis of the consumption of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from humans and food-producing animals, 2015 pdf icon[PDF – 114 Pages]external icon
- Antimicrobial Resistance in Europe, ECDC, 2011external icon
- The Bacterial Challenge: Time to React, ECDC, 2009external icon
European Commission
- Research, Innovation, and Policy: An Alliance Combating AMR, 2019external icon
- A European One Health Action Plan against Antimicrobial Resistance, 2017 pdf icon[PDF – 24 Pages]external icon
- Progress report on the Action plan against the rising threats from Antimicrobial
Resistance, 2015 pdf icon[PDF – 47 Pages]external icon - Action plan against the rising threats from Antimicrobial Resistance, 2011 pdf icon[PDF – 17 Pages]external icon
European Food Safety Authority
- INNUENDO: A Cross‐sectoral Platform for the Integration of Genomics in the Surveillance of Food‐borne Pathogens (2018)external icon
- Final Report of ENGAGE ‐ Establishing Next Generation Sequencing Ability for Genomic Analysis in Europe (2018)external icon
- Outcome of EC/EFSA Questionnaire on use of Whole Genome Sequencing for Food‐ and Waterborne Pathogens Isolated from Animals, Food, Feed, and Related Environmental Samples (2018)external icon
- Comparative Genomics of Quinolone‐resistant and Susceptible Campylobacter Jejuni of Poultry Origin from major Poultry Producing European Countries (2018)external icon
- ECDC, EFSA, EMA Joint Scientific Opinion on a List of Outcome Indicators as Regards Surveillance of AMR and Antimicrobial Consumption in Humans and Food-producing Animals (2017) external icon
- ECDC, EFSA, EMA Second Joint Report on the Integrated Analysis of the Consumption of Antimicrobial Agents and Occurrence of AMR in Bacteria from Humans and Food-producing Animals (2017)external icon
- Risk for the Development of AMR due to Feeding of Calves with Milk Containing Residues of Antibiotics (2017)external icon
- EMA, EFSA Joint Scientific Opinion on Measures to Reduce the need to use Antimicrobial Agents in Animal Husbandry in the European Union, and the Resulting Impacts on Food Safety (2016)external icon
- The EU Summary Report on AMR in Zoonotic and Indicator Bacteria from Humans, Animals, and Food in 2016external icon
- The EU Summary Report on AMR in Zoonotic and Indicator Bacteria from Humans, Animals, and Food in 2015external icon
- The EU Summary Report on AMR in Zoonotic and Indicator Bacteria from Humans, Animals, and Food in 2014external icon
- The EU Summary Report on AMR in Zoonotic Indicator Bacteria from Humans, Animals, and Food in 2013 external icon
- ECDC, EFSA, EMA First Joint Report on the Integrated Analysis of the Consumption of Antimicrobial Agents and Occurrence of AMR in Bacteria from Humans and Food-producing Animals (2015)external icon
European Medicines Agency
- Tenth European Surveillance of Veterinary Antimicrobial Consumption Report: Sales of veterinary antimicrobial agents in 31 European countries, 2018 pdf icon[PDF – 104 Pages]external icon
- Report on the event “Best use of medicines legislation to bring new antibiotics to patients and combat the resistance problem” pdf icon[PDF – 4 Pages]external icon
Public Health Agency of Canada
U.S. Food and Drug Administration
- Potential Approach for Ranking of Antimicrobial Drugs According to Their Importance in Human Medicine: A Risk Management Tool for Antimicrobial New Animal Drugs [PDF – 17 Pages]external icon
- FDA Holds Virtual Public Meeting to Discuss Potential Approach for Ranking of Antimicrobial Drugs According to Their Importance in Human Medicine: A Risk Management Tool for Antimicrobial Animal Drugsexternal icon
- Guidance for Industry #209, The Judicious Use of Medically Important Antibiotics in Food Producing Animals, FDA, 2012 pdf icon[PDF – 26 Pages]external icon
U.S. National Institute of Allergy and Infectious Diseases
Antimicrobial Resistance Funding
Find funding opportunities related to AMR on the agency or organization website or reach out to a contact listed for more information.
| Organization | Contact | Funding Opportunities |
|---|---|---|
| Biomedical Advanced Research and Development Authority (BARDA) | Mark Albrecht, Mark.Albrecht@hhs.gov | |
| Canadian Institutes of Health Research | Edith Brochu, edith.brochu@cihr-irsc.gc.ca | |
| CARB-X | ||
| CDC | Rachael Aubert, vrl7@cdc.gov | |
| Directorate-General for Research and Innovation | Arjon van Hengel, Adrianus.Van-Hengel@ec.europa.eu | |
| Innovative Medicines Initiative | ||
| Joint Programming Initiative on AMR | Edith Brochu, edith.brochu@cihr-irsc.gc.ca | |
| National Institute of Health | Jane Knisely, kniselyj@niaid.nih.gov | |
| Norwegian Institute of Public Health | Christine Årdal, christine.ardal@fhi.no | |
| U.S. Department of Agriculture | Kathe Bjork, kathe.e.bjork@usda.gov |
Page last reviewed: June 7, 2021